2026 NPPES data Cardiovascular Disease Physician NPI 1437312584 M.D.
Verify on CMS →

TULSIDAS KURUVANKA, M.D.

Cardiovascular Disease Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 365 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.9615/100
▲ 4 pts above national avg 83.1 · [object Object]
Industry payments
$2.1K
44 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

TULSIDAS KURUVANKA, M.D. reported a CMS MIPS final score of 86.9615/100 — above the 83.1 national average — and filed 2,989 Medicare Part D claims in 2023.

86.9615/100
MIPS score · +4 vs avg
3K
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

TULSIDAS KURUVANKA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

87 Top 48% higher than 52% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

TULSIDAS KURUVANKA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about TULSIDAS KURUVANKA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 07/09/2008

NPI 1437312584

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

2,989 1% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

MIPS final score

86.9615/100 3.8615000000000066% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Cardiovascular Disease Physician compares to other specialties among Texas providers

Texas providers

Cardiovascular Disease Physician share within Texas

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within Texas

Medicare quality performance — MIPS

TULSIDAS KURUVANKA, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average

High performer (top quartile)
MIPS Final Score
86.9615/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Cardiovascular Disease Physician) — 86.9615/100 vs national avg 83.1

0%100%National avg83%87%
MIPS final score (Cardiovascular Disease Physician) — 86.9615/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

TULSIDAS KURUVANKA, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.D. credentials at 13325 HARGRAVE, HOUSTON, TX, 77070, with a listed phone of (281) 469-8007. NPI 1437312584 was issued on 07/09/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KURUVANKA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,989 prescription claims written by this provider, covering 365 Medicare beneficiaries and totaling roughly $527K in drug spend, split 18% brand-name and 82% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.9615/100 for the 2023 performance year (Quality 99.712, Cost 40.2555), compared with the national average of 83.1.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

13325 HARGRAVE
HOUSTON, TX 77070

Provider Details

NPI 1437312584
Specialty Cardiovascular Disease Physician
Credentials M.D.
Gender Male
NPI Issued 07/09/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

86.9615
Final Score
Avg: 83.1
99.712
Quality
40.2555
Cost

Reporting: Group practice

Hospital and facility affiliations

Facilities where TULSIDAS KURUVANKA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CARDIOVASCULAR SPECIALISTS OF WILLOWBROOK PLLC
HOUSTON, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for TULSIDAS KURUVANKA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.1K

Largest payer

Boston Scientific Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to TULSIDAS KURUVANKA, M.D.. To verify TULSIDAS KURUVANKA, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

TULSIDAS KURUVANKA, M.D. — brand share 18.0%
Specialty average (est.)

18% brand-name claims vs 82% generic, on 2,989 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,989
Total Claims
$527K
Total Drug Cost
365
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,215
Total Day Supply
215,013
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$468K
Generic Drug Cost
$60K
Antibiotic Claims
21

Patient Demographics

Average Patient Age
74.6 years
Avg HCC Risk Score
2.16
Gender Split
54% female / 46% male
Age Distribution
<65: 32, 65-74: 149, 75-84: 140, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What TULSIDAS KURUVANKA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Carvedilol
309
Clopidogrel
Clopidogrel Bisulfate
251
Eliquis
Apixaban
205
Losartan Potassium
194
Atorvastatin Calcium
182
Amlodipine Besylate
134
Lisinopril
116
Metoprolol Succinate
112
Xarelto
Rivaroxaban
107
Entresto
Sacubitril/Valsartan
103

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How TULSIDAS KURUVANKA, M.D. fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

TULSIDAS KURUVANKA, M.D.'s 2,989 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as KURUVANKA.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is TULSIDAS KURUVANKA, M.D.'s specialty?
TULSIDAS KURUVANKA, M.D. specializes in Cardiovascular Disease Physician and practices in HOUSTON, Texas. Credentials: M.D..
How much does TULSIDAS KURUVANKA, M.D. prescribe under Medicare Part D?
In 2023, TULSIDAS KURUVANKA, M.D. wrote 2,989 Medicare Part D claims totaling $527K in drug costs for 365 beneficiaries.
What is TULSIDAS KURUVANKA, M.D.'s Medicare quality score?
TULSIDAS KURUVANKA, M.D. has a CMS MIPS Final Score of 86.9615/100 (Quality: 99.712, Cost: 40.2555). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is TULSIDAS KURUVANKA, M.D. located?
TULSIDAS KURUVANKA, M.D. is located at 13325 HARGRAVE, HOUSTON, TX, 77070. Phone: (281) 469-8007.
What is TULSIDAS KURUVANKA, M.D.'s NPI number?
TULSIDAS KURUVANKA, M.D.'s National Provider Identifier (NPI) is 1437312584, issued on 07/09/2008.
Does TULSIDAS KURUVANKA, M.D. prescribe more brand-name or generic drugs?
TULSIDAS KURUVANKA, M.D.'s prescribing is 18% brand-name and 82% generic drugs by claim count, with $468K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does TULSIDAS KURUVANKA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, TULSIDAS KURUVANKA, M.D.'s most frequently prescribed drugs include Carvedilol, Clopidogrel, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does TULSIDAS KURUVANKA, M.D. accept Medicare?
TULSIDAS KURUVANKA, M.D. appears in CMS Medicare data with 2,989 Part D claims and 365 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify TULSIDAS KURUVANKA, M.D.'s credentials?
TULSIDAS KURUVANKA, M.D.'s NPI is 1437312584 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology